Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for Breast Cancer Related Lymphedema
NCT02895724Phase 2Unknown
- Sponsor
- Kræftens Bekæmpelse
- Start
- Sep 2016
- Primary completion
- Dec 2018
- Modality
- Inhalation Devices
01
Overview
Phase 2, open-label trial of oxygen in lymphedema (2 arms), sponsored by Kræftens Bekæmpelse. Primary endpoint: Arm volume at 8 months. Status: unknown.
02
Drugs
oxygen
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT02895724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02895724.